GAD1 and cranioectodermal dysplasia: Patients affected by Hashimoto’s thyroiditis and Graves’ disease show a higher prevalence of CeD, while the association between CeD and type 1 diabetes is supported by a significant correlation between anti-GAD antibodies, anti-thyroglobulin antibodies, and CeD [73].